Brzeziński, P.; Feszak, I.J.; Śmigielski, J.; Kawczak, P.; Bączek, T.
Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations. J. Clin. Med. 2025, 14, 3497.
https://doi.org/10.3390/jcm14103497
AMA Style
Brzeziński P, Feszak IJ, Śmigielski J, Kawczak P, Bączek T.
Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations. Journal of Clinical Medicine. 2025; 14(10):3497.
https://doi.org/10.3390/jcm14103497
Chicago/Turabian Style
Brzeziński, Piotr, Igor Jarosław Feszak, Janusz Śmigielski, Piotr Kawczak, and Tomasz Bączek.
2025. "Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations" Journal of Clinical Medicine 14, no. 10: 3497.
https://doi.org/10.3390/jcm14103497
APA Style
Brzeziński, P., Feszak, I. J., Śmigielski, J., Kawczak, P., & Bączek, T.
(2025). Compliance with the European Pregnancy Prevention Programme in Isotretinoin Treatment: Safety Outcomes and Dose-Related Correlations. Journal of Clinical Medicine, 14(10), 3497.
https://doi.org/10.3390/jcm14103497